Encounter:
  encounterContactModes:
    conceptId: C171445
    definition: Terminology relevant to the means by which interaction occurs between
      the subject and person or entity.
    extensible: 'true'
    name: Mode of Subject Contact
    preferredTerm: CDISC SDTM Mode of Subject Contact Terminology
    submissionValue: CNTMODE
    synonyms:
    - Mode of Subject Contact
    terms:
    - conceptId: C175574
      definition: An interaction that takes place in the physical presence of someone
        else.
      preferredTerm: In Person
      submissionValue: IN PERSON
      synonyms:
      - In-Person
    - conceptId: C177933
      definition: A type of automated system in which individuals can access information
        menus containing pre-recorded or dynamically generated information with voice
        prompts, without the need for an agent or operator.
      preferredTerm: Interactive Voice Response System
      submissionValue: IVRS
      synonyms:
      - Interactive Voice Response System
    - conceptId: C171525
      definition: A form of remote communication by audio video technology.
      preferredTerm: Audio-Videoconferencing
      submissionValue: REMOTE AUDIO VIDEO
    - conceptId: C171524
      definition: A form of remote communication by audio technology.
      preferredTerm: Audioconferencing
      submissionValue: REMOTE AUDIO
    - conceptId: C171533
      definition: Receipt of shipped material was confirmed by signature.
      preferredTerm: Shipment Confirmed by Signature
      submissionValue: SHIPMENT CONFIRMED BY SIGNATURE
    - conceptId: C171537
      definition: Communication by way of telephone.
      preferredTerm: Telephone Call
      submissionValue: TELEPHONE CALL
  encounterEnvironmentalSetting:
    conceptId: C127262
    definition: Terminology relevant to the surroundings or environment.
    extensible: 'true'
    name: Environmental Setting
    preferredTerm: CDISC SDTM Environmental Setting Terminology
    submissionValue: SETTING
    synonyms:
    - Environmental Setting
    terms:
    - conceptId: C127785
      definition: An establishment that provides care for infants and children.
      preferredTerm: Childcare Center
      submissionValue: CHILD CARE CENTER
    - conceptId: C51282
      definition: A health care facility where subjects or patients may receive assessments,
        procedures, or treatments that are provided by physicians and other healthcare
        providers.
      preferredTerm: Clinic
      submissionValue: CLINIC
    - conceptId: C48953
      definition: A tract of land cultivated for the purpose of agricultural production
        or devoted to the raising and breeding of domestic animals.
      preferredTerm: Farm
      submissionValue: FARM
    - conceptId: C102650
      definition: A setting outside the clinic or a comparable health care facility,
        e.g. a doctor's office, the subject's home or workplace, a school, a public
        park, or a restaurant.
      preferredTerm: In the Field
      submissionValue: FIELD
    - conceptId: C21541
      definition: The buildings and organizations where healthcare services are provided.
      preferredTerm: Healthcare Facility
      submissionValue: HEALTH FACILITY
    - conceptId: C18002
      definition: A person's place of residence.
      preferredTerm: Home
      submissionValue: HOME
    - conceptId: C16696
      definition: An institution that provides medical, surgical, or psychiatric care
        and treatment for the sick or the injured.
      preferredTerm: Hospital
      submissionValue: HOSPITAL
    - conceptId: C102647
      definition: The area in which an individual lives.
      preferredTerm: Household Environment
      submissionValue: HOUSEHOLD ENVIRONMENT
    - conceptId: C41206
      definition: An established society, corporation, foundation or other organization
        founded and united for a specific purpose, e.g. for health-related research;
        also used to refer to a building or buildings occupied or used by such organization.
      preferredTerm: Institution
      submissionValue: INSTITUTION
    - conceptId: C181529
      definition: A motorized conveyance for people and goods.
      preferredTerm: Motor Vehicle
      submissionValue: MOTOR VEHICLE
    - conceptId: C102679
      definition: An area outside of that in which an individual lives.
      preferredTerm: Non-household Environment
      submissionValue: NON-HOUSEHOLD ENVIRONMENT
    - conceptId: C181530
      definition: Any environmental setting outside of a clinic.
      preferredTerm: Not In Clinic
      submissionValue: NOT IN CLINIC
    - conceptId: C16281
      definition: A medical care center that provides healthcare services on an outpatient
        basis.
      preferredTerm: Ambulatory Care Facility
      submissionValue: OUTPATIENT CLINIC
    - conceptId: C85862
      definition: An institution where persons are confined for punishment and to
        protect the public.
      preferredTerm: Correctional Institution
      submissionValue: PRISON
    - conceptId: C17118
      definition: An educational institution.
      preferredTerm: School
      submissionValue: SCHOOL
    - conceptId: C85863
      definition: Temporary housing for displaced or at-risk persons.
      preferredTerm: Shelter
      submissionValue: SHELTER
    - conceptId: C102712
      definition: The surroundings or environment in which social activities occur.
      preferredTerm: Social Setting
      submissionValue: SOCIAL SETTING
    - conceptId: C17556
      definition: Place or physical location of work or employment.
      preferredTerm: Worksite
      submissionValue: WORKSITE
  encounterType:
    conceptId: C188728
    definition: The terminology relevant to the encounter type.
    extensible: ''
    name: Encounter Type Value Set Terminology
    preferredTerm: CDISC DDF Encounter Type Value Set Terminology
    submissionValue: Encounter Type Value Set Terminology
    synonyms:
    - Encounter Type Value Set Terminology
    terms:
    - conceptId: C25716
      definition: The act of going to see some person or place or thing; it can cover
        a short or long period but refers to a non-permanent arrangement.
      preferredTerm: Visit
      submissionValue: Visit
      synonyms: []
Endpoint:
  endpointLevel:
    conceptId: C188726
    definition: The terminology relevant to the endpoint level.
    extensible: ''
    name: Endpoint Level Value Set Terminology
    preferredTerm: CDISC DDF Endpoint Level Value Set Terminology
    submissionValue: Endpoint Level Value Set Terminology
    synonyms:
    - Endpoint Level Value Set Terminology
    terms:
    - conceptId: C170559
      definition: Endpoint(s) that may include clinically important events that are
        expected to occur too infrequently to show a treatment effect or endpoints
        that for other reasons are thought to be less likely to show an effect but
        are included to explore new hypotheses. (After FDA-NIH Protocol Template)
      preferredTerm: Exploratory Endpoint
      submissionValue: Exploratory Endpoint
      synonyms: []
    - conceptId: C94496
      definition: Endpoint(s) of greatest importance that is the basis for concluding
        whether the study met its objective(s) and provides a clinically relevant,
        valid, and reliable measure of the primary objective(s). (After FDA-NIH Protocol
        Template)
      preferredTerm: Primary Endpoint
      submissionValue: Primary Endpoint
      synonyms: []
    - conceptId: C139173
      definition: Endpoint(s) that may provide supportive information about the effect
        of the study intervention(s) on the primary endpoint or demonstrate additional
        effects on the disease or condition. (After FDA-NIH Protocol Template)
      preferredTerm: Secondary Endpoint
      submissionValue: Secondary Endpoint
      synonyms: []
Objective:
  objectiveLevel:
    conceptId: C188725
    definition: The terminology relevant to the objective level.
    extensible: ''
    name: Objective Level Value Set Terminology
    preferredTerm: CDISC DDF Objective Level Value Set Terminology
    submissionValue: Objective Level Value Set Terminology
    synonyms:
    - Objective Level Value Set Terminology
    terms:
    - conceptId: C85826
      definition: A principle objective of the study.
      preferredTerm: Trial Primary Objective
      submissionValue: Study Primary Objective
      synonyms:
      - Study Primary Objective
      - Trial Primary Objective
    - conceptId: C85827
      definition: An auxiliary objective of the study.
      preferredTerm: Trial Secondary Objective
      submissionValue: Study Secondary Objective
      synonyms:
      - Study Secondary Objective
      - Trial Secondary Objective
Organization:
  organizationType:
    conceptId: C188724
    definition: The terminology relevant to the organization type.
    extensible: ''
    name: Organization Type Value Set Terminology
    preferredTerm: CDISC DDF Organization Type Value Set Terminology
    submissionValue: Organization Type Value Set Terminology
    synonyms:
    - Organization Type Value Set Terminology
    terms:
    - conceptId: Clinical Study Registry
      definition: An organization (typically a government agency) that administers
        the registration of studies. (BRIDG)
      preferredTerm: Study Registry
      submissionValue: Clinical Study Registry
      synonyms: []
    - conceptId: C70793
      definition: An entity that is responsible for the initiation, management, and/or
        financing of a clinical study.
      preferredTerm: Clinical Study Sponsor
      submissionValue: Clinical Study Sponsor
      synonyms:
      - Clinical Study Sponsor
      - Sponsor
      - Study Sponsor
    - conceptId: C188863
      definition: An organization (typically a government agency) that is responsible
        for implementing and enforcing laws, licensing and regulating products and
        services, promoting the use of standards, and ensuring safety and consumer
        protections.
      preferredTerm: Regulatory Agency
      submissionValue: Regulatory Agency
      synonyms:
      - Regulator
      - Regulatory Body
Study:
  studyPhase:
    conceptId: C66737
    definition: A terminology codelist relevant to the phase, or stage, of the clinical
      trial.
    extensible: 'true'
    name: Trial Phase Response
    preferredTerm: CDISC SDTM Trial Phase Terminology
    submissionValue: TPHASE
    synonyms:
    - Trial Phase Response
    terms:
    - conceptId: C48660
      definition: Determination of a value is not relevant in the current context.
        (NCI)
      preferredTerm: Not Applicable
      submissionValue: NOT APPLICABLE
      synonyms:
      - NA
      - Not Applicable
    - conceptId: C54721
      definition: 'First-in-human trials, in a small number of subjects, that are
        conducted before Phase 1 trials and are intended to assess new candidate therapeutic
        and imaging agents. The study agent is administered at a low dose for a limited
        time, and there is no therapeutic or diagnostic intent. NOTE: FDA Guidance
        for Industry, Investigators, and Reviewers: Exploratory IND Studies, January
        2006 classifies such studies as Phase 1. NOTE: A Phase 0 study might not include
        any drug delivery but may be an exploration of human material from a study
        (e.g., tissue samples or biomarker determinations). [Improving the Quality
        of Cancer Clinical Trials: Workshop summary-Proceedings of the National Cancer
        Policy Forum Workshop, improving the Quality of Cancer Clinical Trials (Washington,
        DC, Oct 2007)] (CDISC glossary)'
      preferredTerm: Phase 0 Trial
      submissionValue: PHASE 0 TRIAL
      synonyms:
      - '0'
      - Pre-clinical Trial
      - Trial Phase 0
    - conceptId: C15600
      definition: 'The initial introduction of an investigational new drug into humans.
        Phase 1 studies are typically closely monitored and may be conducted in patients
        or normal volunteer subjects. NOTE: These studies are designed to determine
        the metabolism and pharmacologic actions of the drug in humans, the side effects
        associated with increasing doses, and, if possible, to gain early evidence
        on effectiveness. During Phase 1, sufficient information about the drug''s
        pharmacokinetics and pharmacological effects should be obtained to permit
        the design of well-controlled, scientifically valid, Phase 2 studies. The
        total number of subjects and patients included in Phase I studies varies with
        the drug, but is generally in the range of 20 to 80. Phase 1 studies also
        include studies of drug metabolism, structure-activity relationships, and
        mechanism of action in humans, as well as studies in which investigational
        drugs are used as research tools to explore biological phenomena or disease
        processes. [After FDA CDER Handbook, ICH E8] (CDISC glossary)'
      preferredTerm: Phase I Trial
      submissionValue: PHASE I TRIAL
      synonyms:
      - '1'
      - Trial Phase 1
    - conceptId: C15693
      definition: A class of clinical study that combines elements characteristic
        of traditional Phase I and Phase II trials. See also Phase I, Phase II.
      preferredTerm: Phase I/II Trial
      submissionValue: PHASE I/II TRIAL
      synonyms:
      - 1-2
      - Trial Phase 1-2
    - conceptId: C15601
      definition: 'Phase 2. Controlled clinical studies conducted to evaluate the
        effectiveness of the drug for a particular indication or indications in patients
        with the disease or condition under study and to determine the common short-term
        side effects and risks associated with the drug. NOTE: Phase 2 studies are
        typically well controlled, closely monitored, and conducted in a relatively
        small number of patients, usually involving no more than several hundred subjects.
        [After FDA CDER Handbook, ICH E8] (CDISC glossary)'
      preferredTerm: Phase II Trial
      submissionValue: PHASE II TRIAL
      synonyms:
      - '2'
      - Trial Phase 2
    - conceptId: C15694
      definition: A class of clinical study that combines elements characteristic
        of traditional Phase II and Phase III trials.
      preferredTerm: Phase II/III Trial
      submissionValue: PHASE II/III TRIAL
      synonyms:
      - 2-3
      - Trial Phase 2-3
    - conceptId: C49686
      definition: A clinical research protocol generally referred to as a pilot or
        feasibility trial that aims to prove the concept of the new intervention in
        question. (NCI)
      preferredTerm: Phase IIa Trial
      submissionValue: PHASE IIA TRIAL
      synonyms:
      - 2A
      - Trial Phase 2A
    - conceptId: C49688
      definition: A clinical research protocol generally referred to as a well-controlled
        and pivotal trial that aims to prove the mechanism of action of the new intervention
        in question. A pivotal study will generally be well-controlled, randomized,
        of adequate size, and whenever possible, double-blind. (NCI)
      preferredTerm: Phase IIb Trial
      submissionValue: PHASE IIB TRIAL
      synonyms:
      - 2B
      - Trial Phase 2B
    - conceptId: C15602
      definition: 'Phase 3. Studies are expanded controlled and uncontrolled trials.
        They are performed after preliminary evidence suggesting effectiveness of
        the drug has been obtained, and are intended to gather the additional information
        about effectiveness and safety that is needed to confirm efficacy and evaluate
        the overall benefit-risk relationship of the drug and to provide an adequate
        basis for physician labeling. NOTE: Phase 3 studies usually include from several
        hundred to several thousand subjects. [After FDA CDER Handbook, ICH E8] (CDISC
        glossary)'
      preferredTerm: Phase III Trial
      submissionValue: PHASE III TRIAL
      synonyms:
      - '3'
      - Trial Phase 3
    - conceptId: C49687
      definition: A classification typically assigned retrospectively to a Phase III
        trial upon determination by regulatory authorities of a need for a Phase III
        B trial. (NCI)
      preferredTerm: Phase IIIa Trial
      submissionValue: PHASE IIIA TRIAL
      synonyms:
      - 3A
      - Trial Phase 3A
    - conceptId: C49689
      definition: 'A subcategory of Phase III trials done near the time of approval
        to elicit additional findings. NOTE: Dossier review may continue while associated
        Phase IIIB trials are conducted. These trials may be required as a condition
        of regulatory authority approval.'
      preferredTerm: Phase IIIb Trial
      submissionValue: PHASE IIIB TRIAL
      synonyms:
      - 3B
      - Trial Phase 3B
    - conceptId: C15603
      definition: 'Phase 4. Postmarketing (Phase 4) studies to delineate additional
        information about the drug''s risks, benefits, and optimal use that may be
        requested by regulatory authorities in conjunction with marketing approval.
        NOTE: These studies could include, but would not be limited to, studying different
        doses or schedules of administration than were used in Phase 2 studies, use
        of the drug in other patient populations or other stages of the disease, or
        use of the drug over a longer period of time. [After FDA CDER Handbook, ICH
        E8] (CDISC glossary)'
      preferredTerm: Phase IV Trial
      submissionValue: PHASE IV TRIAL
      synonyms:
      - '4'
      - Trial Phase 4
    - conceptId: C47865
      definition: Postmarketing surveillance is sometimes referred to as Phase V.
      preferredTerm: Phase V Trial
      submissionValue: PHASE V TRIAL
      synonyms:
      - '5'
      - Trial Phase 5
  studyType:
    conceptId: C99077
    definition: A terminology codelist relevant to the role the study plays in determining
      the interventions a subject receives.
    extensible: 'false'
    name: Study Type Response
    preferredTerm: CDISC SDTM Study Type Terminology
    submissionValue: STYPE
    synonyms:
    - Study Type Response
    terms:
    - conceptId: C98722
      definition: Studies that provide a means for obtaining an experimental drug
        or device for patients who are not adequately treated by existing therapy,
        who do not meet the eligibility criteria for enrollment, or who are otherwise
        unable to participate in another clinical study. Expanded Access studies include
        individual-patient IND, treatment IND, compassionate use, emergency use or
        continued access.
      preferredTerm: Expanded Access Study
      submissionValue: EXPANDED ACCESS
    - conceptId: C98388
      definition: Studies in which individuals are assigned by an investigator based
        on a protocol to receive specific interventions. Subjects may receive diagnostic,
        therapeutic or other types of interventions. The assignment of the intervention
        may or may not be random. The individuals are then followed and biomedical
        and/or health outcomes are assessed.
      preferredTerm: Interventional Study
      submissionValue: INTERVENTIONAL
    - conceptId: C16084
      definition: Studies in which biomedical and/or health outcomes are assessed
        in pre-defined groups of individuals. Subjects in the study may receive diagnostic,
        therapeutic, or other interventions, but the investigator does not assign
        specific interventions to the subjects of the study.
      preferredTerm: Observational Study
      submissionValue: OBSERVATIONAL
    - conceptId: C129000
      definition: Observational studies which include an organized system that uses
        observational methods to collect uniform data (clinical and other) prospectively
        for a population defined by a particular disorder/disease, condition (including
        susceptibility to a disorder), or exposure (including products, health care
        services, and/or procedures) and that serves a predetermined scientific, clinical,
        or policy purpose. Patient registries may be single purpose or on-going data
        collection programs that address one or more questions. (AHRQ)
      preferredTerm: Patient Registry Study
      submissionValue: PATIENT REGISTRY
StudyArm:
  studyArmDataOriginType:
    conceptId: C188727
    definition: The terminology relevant to the study arm data origin type.
    extensible: ''
    name: Study Arm Data Origin Type Value Set Terminology
    preferredTerm: CDISC DDF Study Arm Data Origin Type Value Set Terminology
    submissionValue: Study Arm Data Origin Type Value Set Terminology
    synonyms:
    - Study Arm Data Origin Type Value Set Terminology
    terms:
    - conceptId: C188866
      definition: Data that are generated from the current study.
      preferredTerm: Data Generated Within Study
      submissionValue: Data Generated Within Study
      synonyms: []
    - conceptId: C188864
      definition: Data from studies that have occurred in the past.
      preferredTerm: Historical Data
      submissionValue: Historical Data
      synonyms: []
    - conceptId: C165830
      definition: 'Data relating to patient health status and/or the delivery of health
        care routinely collected from sources other than traditional clinical trials.
        NOTE: Examples of sources include data derived from electronic health records
        (EHRs); medical claims and billing data; data from product and disease registries;
        patient-generated data, including from in-home-use settings; and data gathered
        from other sources that can inform on health status, such as mobile devices.
        [After 21 U.S.C. 355g(b)).5 and Framework for FDA''s Real-World Evidence Program
        December 2018] See also Real-World Evidence (RWE)'
      preferredTerm: Real-world Data
      submissionValue: Real World Data
      synonyms: []
    - conceptId: C176263
      definition: 'Data that are artificially created rather than being generated
        by actual events. NOTE: Data are often created with the help of algorithms
        and used for a wide range of activities, including as test data for new products
        and tools, for model validation, and in AI optimization. [After The Ultimate
        Guide to Synthetic Data in 2020, August 29, 2020]. See also artificial intelligence.'
      preferredTerm: Synthetic Data
      submissionValue: Synthetic Data
      synonyms: []
    - conceptId: C188865
      definition: Data that are generated from virtual encounters between investigators
        and subjects.
      preferredTerm: Virtual Data
      submissionValue: Virtual Data
      synonyms: []
  studyArmType:
    conceptId: C174222
    definition: The terminology relevant to the identification of the kind of arm.
    name: Study Arm Type Value Set Terminology
    preferredTerm: CDISC Protocol Study Arm Type Value Set Terminology
    submissionValue: Study Arm Type Value Set Terminology
    synonyms:
    - Study Arm Type Value Set Terminology
    terms:
    - conceptId: C174267
      definition: An arm describing the active comparator.
      preferredTerm: Active Comparator Arm
      submissionValue: Active Comparator Arm
    - conceptId: C174226
      definition: An arm describing the intervention or treatment plan for a group
        of participants in the study receiving a control. The control may comprise
        a non-investigational product (active control) or regimen, placebo, or no
        treatment.
      preferredTerm: Control Arm
      submissionValue: Control Arm
    - conceptId: C174266
      definition: An arm describing the intervention or treatment plan for a group
        of participants in the study receiving test product(s).
      preferredTerm: Investigational Arm
      submissionValue: Experimental Arm
      synonyms:
      - Investigational Arm
    - conceptId: C174270
      definition: A study arm without an intervention or treatment.
      preferredTerm: No Intervention Arm
      submissionValue: No Intervention Arm
    - conceptId: C174268
      definition: An arm describing the placebo comparator.
      preferredTerm: Placebo Control Arm
      submissionValue: Placebo Comparator Arm
      synonyms:
      - Placebo Control Arm
    - conceptId: C174269
      definition: An arm describing the sham comparator.
      preferredTerm: Sham Comparator Arm
      submissionValue: Sham Comparator Arm
      synonyms:
      - Sham Intervention Arm
    - conceptId: C15538
      definition: An arm describing the intervention or treatment plan for a group
        of participants in the study. Treatment may consist of either experimental
        or control products under investigation.
      preferredTerm: Protocol Treatment Arm
      submissionValue: Treatment Arm
StudyDesign:
  interventionModel:
    conceptId: C99076
    definition: A terminology codelist relevant to the trial design developed to compare
      treatment groups.
    extensible: 'true'
    name: Intervention Model Response
    preferredTerm: CDISC SDTM Intervention Model Terminology
    submissionValue: INTMODEL
    synonyms:
    - Intervention Model Response
    terms:
    - conceptId: C82637
      definition: Participants receive one of two or more alternative intervention(s)
        during the initial epoch of the study and receive other intervention(s) during
        the subsequent epoch(s) of the study.
      preferredTerm: Crossover Study
      submissionValue: CROSS-OVER
    - conceptId: C82638
      definition: Two or more interventions, each alone or in combination, are evaluated
        in parallel against a control group. This study design allows for the comparison
        of active drug to placebo, presence of drug-drug interactions, and comparison
        of active drugs against each other.
      preferredTerm: Factorial Study
      submissionValue: FACTORIAL
    - conceptId: C82639
      definition: Participants are assigned to one of two or more treatment groups
        in parallel for the duration of the study.
      preferredTerm: Parallel Study
      submissionValue: PARALLEL
    - conceptId: C142568
      definition: Groups of participants are assigned to receive interventions based
        on prior milestones being reached in the study. (clinicaltrials.gov)
      preferredTerm: Group Sequential Design
      submissionValue: SEQUENTIAL
    - conceptId: C82640
      definition: All trial participants are assigned to a single treatment group
        for the duration of the study.
      preferredTerm: Single Group Study
      submissionValue: SINGLE GROUP
  trialIntentType:
    conceptId: C66736
    definition: A terminology codelist relevant to the responses for the planned purpose
      of the therapy, device, or agent under study in the clinical trial.
    extensible: 'true'
    name: Trial Intent Type Response
    preferredTerm: CDISC SDTM Trial Indication Type Terminology
    submissionValue: TINDTP
    synonyms:
    - Trial Intent Type Response
    terms:
    - conceptId: C15714
      definition: A type of study designed to examine the basic mechanism of action
        (e.g., physiology, biomechanics) of an intervention. (ClinicalTrials.gov)
      preferredTerm: Basic Research
      submissionValue: BASIC SCIENCE
      synonyms:
      - Basic Research
    - conceptId: C49654
      definition: A type of study designed to evaluate intervention(s) aimed to cure
        a disease or condition.
      preferredTerm: Cure Study
      submissionValue: CURE
    - conceptId: C139174
      definition: An intervention of a device product is being evaluated to determine
        the feasibility of the product or to test a prototype device and not health
        outcomes. Such studies are conducted to confirm the design and operating specifications
        of a device before beginning a full clinical trial. (ClinicalTrials.gov)
      preferredTerm: Device Feasibility Study
      submissionValue: DEVICE FEASIBILITY
    - conceptId: C49653
      definition: A type of study designed to evaluate intervention(s) aimed at identifying
        a disease or condition.
      preferredTerm: Diagnosis Study
      submissionValue: DIAGNOSIS
    - conceptId: C170629
      definition: A type of study designed to evaluate the effects of treatment(s)
        intended to cause a change in disease, syndrome, or condition beyond the point
        of treatment administration.
      preferredTerm: Disease Modifying Treatment Study
      submissionValue: DISEASE MODIFYING
    - conceptId: C15245
      definition: A type of study designed to evaluate the delivery, processes, management,
        organization or financing of health care. (ClinicalTrials.gov)
      preferredTerm: Health Services Research
      submissionValue: HEALTH SERVICES RESEARCH
    - conceptId: C49655
      definition: A type of study designed to identify actions necessary to eliminate
        or reduce the risk to human life or well-being as a result of a particular
        medication or treatment regimen. (NCI)
      preferredTerm: Adverse Effect Mitigation Study
      submissionValue: MITIGATION
    - conceptId: C49657
      definition: A type of study designed to identify actions necessary to permanently
        eliminate or reduce the long-term risk to human life as a result of a particular
        medication or treatment regimen.
      preferredTerm: Prevention Study
      submissionValue: PREVENTION
      synonyms:
      - Prophylaxis Study
    - conceptId: C71485
      definition: A type of study designed to assess or examine methods of identifying
        a condition (or risk factors for a condition) in people who are not yet known
        to have the condition (or risk factor). (Clinicaltrials.gov)
      preferredTerm: Screening Study
      submissionValue: SCREENING
    - conceptId: C71486
      definition: A type of study designed to evaluate one or more interventions where
        the primary intent is to maximize comfort, minimize side effects or mitigate
        against a decline in the subject's health or function. In general, supportive
        care interventions are not intended to cure a disease. (ClinicalTrials.gov)
      preferredTerm: Supportive Care Study
      submissionValue: SUPPORTIVE CARE
    - conceptId: C49656
      definition: A type of study designed to evaluate intervention(s) for treatment
        of disease, syndrome or condition.
      preferredTerm: Treatment Study
      submissionValue: TREATMENT
      synonyms:
      - Therapy Trial
  trialType:
    conceptId: C66739
    definition: A terminology codelist relevant to the type of primary outcome or
      endpoint that the protocol is designed to evaluate.
    extensible: 'true'
    name: Trial Type Response
    preferredTerm: CDISC SDTM Trial Type Terminology
    submissionValue: TTYPE
    synonyms:
    - Trial Type Response
    terms:
    - conceptId: C158283
      definition: A type of study designed to evaluate the strength of the bond between
        an adhesive and the application surface.
      preferredTerm: Adhesion Performance Study
      submissionValue: ADHESION PERFORMANCE
    - conceptId: C158284
      definition: A type of study designed to evaluate the effects of alcohol on investigational
        product safety and/or efficacy.
      preferredTerm: Alcohol Effect Study
      submissionValue: ALCOHOL EFFECT
    - conceptId: C49664
      definition: A study of the degree to which or rate at which a drug or other
        substance is absorbed or becomes available at the site of physiological activity
        after administration. (NCI)
      preferredTerm: Bioavailability Study
      submissionValue: BIO-AVAILABILITY
    - conceptId: C49665
      definition: A study most often used to compare the efficacy of different formulations
        to treat a given disease. It is the testing of an old versus a new formulation
        in healthy volunteers or subjects with the disease under study and usually
        in one dose. (NCI)
      preferredTerm: Therapeutic Equivalency Study
      submissionValue: BIO-EQUIVALENCE
    - conceptId: C158288
      definition: A type of study designed to evaluate whether a biologic test article
        is highly similar in function and effect to an existing biologic that has
        already been clinically tested and approved for use.
      preferredTerm: Biosimilarity Study
      submissionValue: BIOSIMILARITY
    - conceptId: C158285
      definition: A type of study designed to evaluate the interaction between a device
        and a drug, where the use of one may affect the disposition, function, efficacy,
        or safety of the other.
      preferredTerm: Device-Drug Interaction Study
      submissionValue: DEVICE-DRUG INTERACTION
    - conceptId: C49653
      definition: A type of study designed to evaluate intervention(s) aimed at identifying
        a disease or condition.
      preferredTerm: Diagnosis Study
      submissionValue: DIAGNOSIS
    - conceptId: C158289
      definition: An early phase clinical study with the objective of determining
        the optimal dose of an investigational product.
      preferredTerm: Dose Finding Study
      submissionValue: DOSE FINDING
    - conceptId: C158290
      definition: A type of study designed to evaluate the relationship between dose
        and resulting exposure.
      preferredTerm: Dose Proportionality Study
      submissionValue: DOSE PROPORTIONALITY
    - conceptId: C127803
      definition: A study of the effect of dose changes on the efficacy of a drug
        in order to determine the dose-response relationship and optimal dose of a
        therapy.
      preferredTerm: Dose Response Study
      submissionValue: DOSE RESPONSE
    - conceptId: C158286
      definition: A type of study designed to evaluate the interaction between drugs,
        where the use of one may affect the disposition, efficacy, or safety of the
        other.
      preferredTerm: Drug-Drug Interaction Study
      submissionValue: DRUG-DRUG INTERACTION
    - conceptId: C178057
      definition: A study that evaluates the effect of a treatment on cardiac electrical
        activity, as assessed by electrocardiography.
      preferredTerm: Electrocardiographic Study
      submissionValue: ECG
      synonyms:
      - Electrocardiographic Study
    - conceptId: C49666
      definition: A study of the relative therapeutic efficacy of treatment of a disease.
        Usually this is a Phase II or III study. (NCI)
      preferredTerm: Efficacy Study
      submissionValue: EFFICACY
    - conceptId: C98729
      definition: Studies that are conducted to assess the effect of food on the rate
        and extent of absorption of a drug, either compared to a fasted state or to
        a reference drug.
      preferredTerm: Food Effect Study
      submissionValue: FOOD EFFECT
    - conceptId: C120842
      definition: A study that assesses an agent's ability to provoke an immune response.
      preferredTerm: Immunogenicity Study
      submissionValue: IMMUNOGENICITY
    - conceptId: C49662
      definition: A study of the biochemical and physiological effect of a drug and
        the mechanism of drug action and the relationship between drug concentration
        and effect. (NCI)
      preferredTerm: Pharmacodynamic Study
      submissionValue: PHARMACODYNAMIC
    - conceptId: C39493
      definition: A study that assesses the value associated with a given drug in
        therapeutic and economic terms. This type of study is multidisciplinary in
        nature and takes into consideration the social and economic costs (resource
        utilization costs including direct, indirect, and intangible costs) of drug
        therapy in addition to its direct therapeutic benefits. Analyses relate the
        difference in therapeutic benefits to the difference in costs between treatment
        alternatives. (NCI)
      preferredTerm: Pharmacoeconomic Study
      submissionValue: PHARMACOECONOMIC
    - conceptId: C129001
      definition: A study that assesses variation in DNA sequence, usually within
        a single gene, and its effect on drug response.
      preferredTerm: Pharmacogenetic Study
      submissionValue: PHARMACOGENETIC
    - conceptId: C49661
      definition: A study that identifies or assesses variations within the entire
        genome, including DNA, RNA, or transcriptional elements, and its effects on
        drug response.
      preferredTerm: Pharmacogenomic Study
      submissionValue: PHARMACOGENOMIC
    - conceptId: C49663
      definition: A study of the process by which a drug is absorbed, distributed,
        metabolized, and eliminated by the body. (NCI)
      preferredTerm: Pharmacokinetic Study
      submissionValue: PHARMACOKINETIC
    - conceptId: C161477
      definition: A type of study designed to evaluate the effect of body position
        during and/or after administration of the investigational product.
      preferredTerm: Position Effect Trial
      submissionValue: POSITION EFFECT
    - conceptId: C49657
      definition: A type of study designed to identify actions necessary to permanently
        eliminate or reduce the long-term risk to human life as a result of a particular
        medication or treatment regimen.
      preferredTerm: Prevention Study
      submissionValue: PREVENTION
      synonyms:
      - Prophylaxis Study
    - conceptId: C174366
      definition: A type of study designed to evaluate the expected, acute types of
        immunological responses, sometimes considered excessive, following agent administration.
      preferredTerm: Reactogenicity Study
      submissionValue: REACTOGENICITY
    - conceptId: C49667
      definition: A study that assesses the medical risks to a subject. Safety is
        usually assessed by examining a wide range of clinical parameters, including
        adverse events, vital signs, physical exam, laboratory tests.
      preferredTerm: Safety Study
      submissionValue: SAFETY
    - conceptId: C161478
      definition: A type of study designed to evaluate the effect of the investigational
        product on the physiologic act of swallowing.
      preferredTerm: Swallowing Function Trial
      submissionValue: SWALLOWING FUNCTION
    - conceptId: C158287
      definition: A type of study designed to evaluate the ability of an investigational
        product and/or approved drug to delay cardiac ventricular repolarization as
        detected by QT prolongation and other ECG parameters.
      preferredTerm: Thorough QT Study
      submissionValue: THOROUGH QT
      synonyms:
      - TQT Study
    - conceptId: C98791
      definition: A type of safety study that assesses the degree to which overt adverse
        effects can be tolerated by the subject.
      preferredTerm: Tolerability Study
      submissionValue: TOLERABILITY
    - conceptId: C49656
      definition: A type of study designed to evaluate intervention(s) for treatment
        of disease, syndrome or condition.
      preferredTerm: Treatment Study
      submissionValue: TREATMENT
      synonyms:
      - Therapy Trial
    - conceptId: C161479
      definition: A type of study designed to evaluate the user experience with a
        product.
      preferredTerm: Usability Testing Study
      submissionValue: USABILITY TESTING
    - conceptId: C161480
      definition: A type of study designed to evaluate the effects of water on investigational
        product safety and/or efficacy.
      preferredTerm: Water Effect Trial
      submissionValue: WATER EFFECT
  studyDesignBlindingSchema:
    conceptId: C99999
    definition: A terminology codelist relevant to the type of primary outcome or
          endpoint that the protocol is designed to evaluate.
    extensible: 'true'
    name: Study Design Blinding Schema
    preferredTerm: CDISC SDTM Study Design Blinding Schema Terminology
    submissionValue: TTYPE
    synonyms:
    - Study Design Blinding Schema
    terms:
    - conceptId: C15228
      definition: A study in which neither the subject nor the study personnel interacting with
       the subject or data during the study knows what intervention a subject is receiving.
      preferredTerm: Double Blind Study
      submissionValue: DOUBLE BLIND
StudyEpoch:
  studyEpochType:
    conceptId: C99079
    definition: The name of the EPOCH.
    extensible: 'true'
    name: Epoch
    preferredTerm: CDISC SDTM Epoch Terminology
    submissionValue: EPOCH
    synonyms:
    - Epoch
    terms:
    - conceptId: C125938
      definition: A period in a clinical study after eligibility has been met and
        before the start of treatment, at which baseline measurements are collected.
      preferredTerm: Baseline Epoch
      submissionValue: BASELINE
    - conceptId: C102255
      definition: A period in a clinical study during which subjects receive blinded
        therapeutic treatment.
      preferredTerm: Blinded Treatment Epoch
      submissionValue: BLINDED TREATMENT
    - conceptId: C123452
      definition: A period in a clinical study during which subjects receive continuation
        treatment.
      preferredTerm: Continuation Therapy Epoch
      submissionValue: CONTINUATION TREATMENT
      synonyms:
      - Continuation Phase
    - conceptId: C99158
      definition: A period in a clinical study during which information about the
        health status of an individual is obtained after study interventions have
        concluded.
      preferredTerm: Clinical Study Follow-up
      submissionValue: FOLLOW-UP
    - conceptId: C123453
      definition: A period in a clinical study during which subjects receive induction
        treatment.
      preferredTerm: Induction Therapy Epoch
      submissionValue: INDUCTION TREATMENT
      synonyms:
      - Induction Phase
      - Intensive Phase
    - conceptId: C16032
      definition: A period in a clinical study during which information about the
        health status of an individual is obtained long after study interventions
        have concluded.
      preferredTerm: Long-term Follow-up
      submissionValue: LONG-TERM FOLLOW-UP
    - conceptId: C165873
      definition: A period in a clinical study during which subjects are observed,
        without any planned intervention.
      preferredTerm: Observation Study Epoch
      submissionValue: OBSERVATION
    - conceptId: C102256
      definition: A period in a clinical study during which subjects receive open
        label therapeutic treatment.
      preferredTerm: Open Label Treatment Epoch
      submissionValue: OPEN LABEL TREATMENT
    - conceptId: C98779
      definition: A period in a clinical study that occurs before the commencement
        of the primary clinical study investigation, during which subjects may be
        assessed for suitability in the clinical study, withdrawn from existing therapy,
        trained in study methodology or evaluated for any other protocol-specified
        reason.
      preferredTerm: Run-in Period
      submissionValue: RUN-IN
    - conceptId: C48262
      definition: A period in a clinical study during which subjects are evaluated
        for participation in the study.
      preferredTerm: Trial Screening
      submissionValue: SCREENING
    - conceptId: C101526
      definition: A period in a study during which subjects are receiving investigational
        therapy or treatment.
      preferredTerm: Treatment Epoch
      submissionValue: TREATMENT
    - conceptId: C42872
      definition: A period of time during a study when a subject is taken off of the
        investigational therapy or treatment in order to reduce the amount of investigational
        product within the body.
      preferredTerm: Washout Period
      submissionValue: WASHOUT
StudyProtocolVersion:
  protocolStatus:
    conceptId: C188723
    definition: The terminology relevant to the protocol status.
    extensible: ''
    name: Protocol Status Value Set Terminology
    preferredTerm: CDISC DDF Protocol Status Value Set Terminology
    submissionValue: Protocol Status Value Set Terminology
    synonyms:
    - Protocol Status Value Set Terminology
    terms:
    - conceptId: C25425
      definition: Acceptance as satisfactory by an authoritative body; established
        by authority; given authoritative approval.
      preferredTerm: Approval
      submissionValue: Approved
      synonyms: []
    - conceptId: C85255
      definition: A preliminary version of a written work, design, or picture.
      preferredTerm: Draft
      submissionValue: Draft
      synonyms: []
    - conceptId: C25508
      definition: Conclusive in a process or progression.
      preferredTerm: Final
      submissionValue: Final
      synonyms: []
    - conceptId: C63553
      definition: No longer in use or valid; old.
      preferredTerm: Obsolete
      submissionValue: Obsolete
      synonyms: []
    - conceptId: C188862
      definition: A preliminary version of a written work, design, or picture that
        is awaiting review.
      preferredTerm: Pending Review
      submissionValue: Pending Review
      synonyms:
      - Draft Pending Review
